The Precision Peptide Genetic Test analyzes pathway-level variants in TCF7L2, and related genes describing baseline metabolism
J Neuroophthalmol 2025
This is the worst the GLP drugs will ever be The smartest person I know in medicine, Dave Park, has told me the only reason surgeons ever have something to do is because medicine hasnt figured out how to solve the problem yet. And in that spirit, todays newsletter is about celebrating the advances in the field of the GLP drugs, which are solving a problem I didnt think medicine would ever solve: curing obesity and metabolic syndrome in our modern food and movement environment
Some studies suggest that long-term use of growth hormone secretagogues like ipamorelin could potentially: increase the risk of certain diseases reduce life expectancy accelerate the aging process However, its crucial to remember that these studies have limitations and more research is needed to fully understand the long-term effects of ipamorelin in humans
About 13.8 mg used through Week 16
[3] Foundayo (orforglipron), approved by the FDA on April 1, 2026, changes that calculus
